semaglutide and sun sensitivity Tirzepatide Exposure: Skin Protection Guide Rybelsus and Sun Exposure: Safety

Description

In the first sensitivity analysis comparing the risk of incident NAION in persons with T2D treated with SGLT2 inhibitors alone ( n = 40,206, reference), once-weekly semaglutide alone ( n = 71,658), and once-weekly semaglutide and SGLT2 inhibitors combined ( n = 45,401), we observed 6 events in 82,877 person-years, 36 events in 178,868 person-years, and 31 events in 119,106 person-years, respectively, corresponding to adjusted HR of 242 (95% CI 097 606) and 262 (95% CI 102674) for once-weekly semaglutide without and with SGLT2 inhibitors in a multivariable model adjusted for sex, age, marital status, duration of diabetes, hemoglobin A1c, estimated glomerular filtration rate, cardiovascular disease, use of insulin, use of cholesterol-lowering medicine, and use of blood pressure lowering medicine

How to Rotate Injection Sites Safely Site rotation prevents lipohypertrophy (thickened fat lumps) and lipodystrophy (thinned skin areas) that can develop when you inject in the exact same spot repeatedly

In 2023, these products generated sales of USD 18.4 billion, and the total GLP-1 market is projected to grow to USD 120 billion by 2030, according to Global Data